Osteoporosis and ischemic cardiovascular disease

Area of Science:

• Cardiology
• Endocrinology
• Gerontology

Background:

• Osteoporosis and cardiovascular disease were historically considered separate conditions.
• Growing evidence demonstrates a significant link between these two diseases.
• Shared risk factors and pathophysiological mechanisms underpin this association.

Purpose of the Study:

• To review epidemiological evidence linking osteoporosis and cardiovascular disease.
• To explore shared pathophysiological mechanisms, including inflammatory cytokines and growth factors.
• To suggest integrated screening and diagnostic approaches for patients with either condition.

Main Methods:

• Review of epidemiological studies on osteoporosis and cardiovascular disease incidence.
• Analysis of pathophysiological pathways involving cytokines (IL-6, TNFα), osteoprotegerin, sclerostin, matrix GLA protein, and FGF-23.
• Synthesis of evidence supporting the link between bone turnover markers and cardiovascular events.

Main Results:

• Patients with osteoporosis or low bone density have increased risk of coronary artery disease and stroke.
• Patients with cardiovascular disease exhibit higher risk of bone loss and fractures.
• Elevated levels of osteoprotegerin, sclerostin, and FGF-23 are associated with both osteoporotic fractures and cardiovascular events.

Conclusions:

• The link between osteoporosis and cardiovascular disease is supported by epidemiological and pathophysiological data.
• Routine bone densitometry and fracture risk assessment in cardiovascular patients are warranted.
• Exercise testing and arterial Doppler imaging may benefit patients with osteoporosis.